{"id":"W2899751126","doi":"10.1016/j.jhep.2018.10.035","title":"Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial","year":2018,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Birmingham Biomedical Research Centre; National Institute for Health and Care Research; NGM Biopharmaceuticals","keywords":"Primary sclerosing cholangitis; Placebo; FGF19; Medicine; Double blind; Internal medicine; Primary (astronomy); Gastroenterology; Randomized controlled trial; Multicenter trial; Multicenter study; Pathology; Physics; Alternative medicine; Disease; Fibroblast growth factor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002004688,0.001843938,0.003641552,0.0004234435,0.0004400573,0.0009647502,0.0008559749,0.002355945,0.005557191],"category_scores_gemma":[0.001858143,0.0006789264,0.001491842,0.0003906869,0.001219158,0.0009339939,0.00034732,0.002046701,0.0009902215],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000508715,"about_ca_system_score_gemma":0.0009917599,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000557424,"about_ca_topic_score_gemma":0.0009134088,"domain_scores_codex":[0.9991099,0.0005228178,0.00005173021,0.0001505048,0.00006843592,0.00009661196],"domain_scores_gemma":[0.9990935,0.0002280535,0.0002144842,0.00007325573,0.00007822106,0.0003124331],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9792256,0.004538794,0.0003228747,0.0006052461,0.0005672356,0.00004390926,0.00003652564,0.0001624069,0.004110901,0.00004811322,0.0005028792,0.009835532],"study_design_scores_gemma":[0.9583347,0.04023347,0.0005886865,0.00001494039,0.0001589106,0.00002381646,0.000008102239,0.0001387296,0.0002441803,0.00003671582,0.0002119427,0.000005748944],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.982771,0.008155467,0.0008075272,0.001036502,0.0005912617,0.003896272,0.0009535198,0.0002008561,0.001587631],"genre_scores_gemma":[0.9815826,0.004080608,0.001925378,0.001249604,0.0006973973,0.006509177,0.001102403,0.00003252083,0.002820421],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005557191,"threshold_uncertainty_score":0.01859063,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02875585533740809,"score_gpt":0.3502835658058485,"score_spread":0.3215277104684404,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}